
Investment Thesis
The convergence of computational tools, synthetic biology, and molecular insight is enabling a future of personalised medicine.
From liquid biopsies to digital biomarkers, we can diagnose earlier & monitor continuously outside hospital allowing prognosis to become more predictable.
Technology is breaking down structural barriers between patients and care, enabling accessible and continuous models.
The traditional model of health is built on sick care, not health care. The future of health will be about maintaining health rather than just waiting for pathogenesis to unfold.
A genuine technical or biological insight that creates defensible advantage.
Teams with rare combinations of domain expertise, vision, and execution ability.
Solutions that address significant unmet medical needs with clear clinical value.
Many great tech isn't translatable to clinical settings. Really understanding how your tech makes the lives of patients & clinicians easier is vital.